Equity-Based Compensation (Tables)

9 Months Ended

Sep. 30, 2011

Equity-Based Compensation [Abstract]

Schedule Of Assumptions Used To Calculate Weighted Average Fair Value Of Stock Option Grants

	9/30/11			10/1/10
Expected volatility		46.5	%		42.0	%
Risk-free interest rate		2.1	%		2.2	%
Expected term (in years)		5.3			5.3
Expected dividend yield		1.5	%		1.0	%

Schedule Of Stock Option Activity

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term (in years)		Aggregate Intrinsic Value (in millions)
Outstanding – beginning of year		26,851,964		$	11.18
Granted		2,238,378		$	5.27
Exercised		(349,348	)	$	1.48
Forfeited/expired		(6,813,634	)	$	20.86
Outstanding – end of period		21,927,360		$	7.72		4.3		$1.0
Exercisable – end of period		18,046,774		$	8.09		3.3		$0.7
Shares vested or expected to vest		21,658,295		$	7.74		4.2		$0.9

Schedule Of Cash-Settled Stock Appreciation Rights Activity

	Shares			Weighted Average Exercise Price
Outstanding – beginning of year		445,233		$	7.73
Granted		74,100		$	4.72
Exercised		(800	)	$	4.12
Forfeited/expired		(58,536	)	$	7.96
Outstanding – end of period		459,997		$	7.22

Schedule Of Restricted Stock Unit Activity

	Shares			Weighted Average Grant Date Fair Value
Non-vested – beginning of year		5,372,417		$	7.19
Granted		2,888,125		$	5.32
Vested		(2,331,904	)	$	6.78
Forfeited		(776,110	)	$	7.09
Non-vested – end of period		5,132,528		$	6.35

Schedule Of Performance Stock Unit Activity

	Shares			Weighted Average Grant Date Fair Value
Non-vested – beginning of year		2,127,318		$	5.86
Granted1		1,838,702		$	5.57
Vested		(798,241	)	$	5.07
Forfeited		(699,676	)	$	7.25
Non-vested – end of period		2,468,103		$	5.51

¹ This includes the additional 183,737 shares from the 2010 grant that were earned based on 2010 operating earnings and strategic goals.  

Schedule Of Equity-Based Compensation Expense

	Third Quarter					Nine Months
	9/30/11		10/1/10			9/30/11			10/1/10
Cost of revenue – products	$	0.4	$	0.6		$	1.3		$	1.6
Cost of revenue – services		0.5		0.6			1.7			1.7
Research and development		2.3		2.3			7.9			6.5
Sales and marketing		1.0		1.5			3.7			4.0
General and administrative		2.1		2.5			7.3			6.9
Equity-based compensation expense before income taxes		6.3		7.5			21.9			20.7
Income tax benefit		—		(2.4	)		(2.6	)		(6.7	)
Total equity-based compensation expense after income taxes	$	6.3	$	5.1		$	19.3		$	14.0

Schedule Of Total Equity-Based Compensation Expense By Type

	Third Quarter				Nine Months
	9/30/11		10/1/10		9/30/11			10/1/10
Stock options	$	1.1	$	1.2	$	3.7		$	3.9
Cash settled SARs		—		0.1		(0.2	)		0.2
Restricted stock		3.8		4.9		13.6			12.4
Performance stock units		1.4		1.3		4.8			4.2
Total	$	6.3	$	7.5	$	21.9		$	20.7